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Edited by Horst FeldmannAbstract Over the past few years, extensive progress has been
made in elucidating the role of calcium in the signaling of
apoptosis. This has led to the characterization of calcium’s role
in the induction of apoptosis and in the regulation of eﬀector
proteases. In this review, we attempt to summarize the current
knowledge regarding a segment of these studies, the interaction
between the endoplasmic reticulum (ER) and mitochondria. This
interface has been shown to play a crucial role in transferring
agonist induced Ca2þ signals to mitochondria during physiolog-
ical processes. Recent evidence, however, extended the role of
this Ca2þ transfer to apoptotic pathways, showing that modu-
lation of mitochondrial Ca2þ uptake from the ER side has a
prominent role in modulating cellular fate.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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(VDAC)1. Introduction
Since the term ‘‘apoptosis’’ was ﬁrst introduced in 1972 by
John Kerr [1] to designate the common morphologic features
of programmed cell death occurring in tissue remodeling [2],
the process has gained enormous importance in normal and
pathological cell conditions. The signiﬁcance of this process is
underscored by the fact that the process and its molecular
components are conserved through virtually all metazoan
species studied so far [3]. As the extensive investigations of the
last three decades disclosed, apoptosis lies in the center of three
fundamental aspects of the life of multicellular organisms.qTheodor B€ucher Lecture.
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tissue development and homeostasis. In parallel, however, it
can also contribute to many forms of pathological cell loss
including Alzheimer’s and Parkinson’s disease and heart fail-
ure. Furthermore, inhibition of apoptosis is a strategy opera-
tive at the basis of the abnormal cell growth in tumors.
The apoptotic pathways running in mammalian cells (having
close homology to the well studied mechanisms in Caenor-
habditis elegans and Drosophila) can have an intrinsic and
extrinsic origin leading equally to the activation of death ef-
fector proteases, the caspases [4]. The activation of these ef-
fector caspases by upstream regulatory members of the
protease family is responsible for the morphological and
functional changes observed during apoptosis, and the versa-
tility of the activation process makes it capable of participating
in a wide range of death patterns. The most important protein
family, which evolved to either up or down-regulate the cas-
pase cascade, is the BCL-2 family of proteins [5], having a
variable number of BCL-2 homology domains (BH 1–4).
These interactions represent an important switch between ap-
optosis induction vs. protection. The single domain, pro-ap-
optotic BH3-only proteins (like BAD, BID, BIM, NOXA and
PUMA) serve as upstream sensors to speciﬁc cell stresses, like
proteolytic activation of BID by caspase-8 after activation of
cell surface death receptors (extrinsic pathway); BAD phos-
phorylation downstream of growth factor receptors; or tran-
scriptional regulation of NOXA and PUMA in p53 induced
apoptosis. Whether their activation leads to ampliﬁcation of
the death process is dictated by the action and interaction of
multi-domain pro-apoptotic (BAX and BAK) and antiapop-
totic (BCL-2, BCL-XL, MCL-1) proteins of the BCL-2 family.
The presence of BAX and BAK is inevitable for virtually all
apoptotic models involving the intrinsic pathway, and together
with their antiapoptotic counterparts, they represent the link
to the next terrain of apoptosis regulation, i.e., the endoplas-
mic reticulum (ER) and mitochondria. The ﬁnal step in ap-
optosis execution, i.e., the formation of the apoptosomes and
activation of caspase-3 initiates from the interplay of these
organelles. Our review will outline this scene with particular
attention to Ca2þ movement between these organelles and its
role in regulating the ﬁnal outcome of cell fate (see Fig. 1).2. Ca2+ enters the contest
The involvement of Ca2þ in cell death has been recognized
almost as early as the apoptotic form of programmed cellblished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representation of the components involved in ER-
mitochondria interaction during Ca2þ mediated apoptotic processes.
Boxes outlined with dashed lines represent diﬀerent units drawn in
diﬀerent functions. (1) Ca2þ transfer from the ER to the mitochondria
through InsP3 receptors, VDAC, tBID and the MCU. (2) Unit of
mitochondrial division, driven by hFis1, Drp-1, comprising cristae of
the IMM, in which cytochrome c is compartmentalized. (3) The per-
meability transition pore (PTP) complex.
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Ca2þ entry into cardiac myoﬁbers causes cell demise, playing a
pathological role in cardiac myopathies [6]. Along these lines,
soon it was demonstrated in several cellular models that Ca2þ
ionophores are highly toxic to cells [7]. The ultimate permit,
however, that let Ca2þ to enter into the ﬁeld of cell death came
from the ﬁndings that pathophysiological overstimulation
of muscle and neural cells at their postsynaptic cholinergic of
glutamate receptors, and the following Ca2þ inﬂux is capable of
inducing cell death [8,9]. Indeed, over the last few years, several
studies have shown that increases of cytosolic Ca2þ concen-
tration ([Ca2þ]c) occur both at early and late stages of the ap-
optotic pathway [10–14]. Ca2þ overload has even been
suggested to be the ﬁnal common pathway of all types of cell
death, with the distinction that very high intracellular Ca2þ
levels can promote cell death through necrosis, whereas lower
intracellular Ca2þ increases induced by milder insults promote
cell death through apoptosis [15,16]. After these initial obser-
vations, a more speciﬁc question which arose is to deﬁne the
participation of diﬀerent Ca2þ sources in speciﬁc types of cell
death. Along these lines, it has been well established that Ca2þ
inﬂux through NMDA receptor channels is chieﬂy responsible
for glutamate induced neurotoxicity [17], but it has also been
suggested that both Ca2þ release from the ER (Ca2þ induced
Ca2þ release through ryanodine receptors in neurons) and the
following capacitative Ca2þ inﬂux are apoptogenic [18–20].
These studies also shed light on the inevitable, but rather un-
speciﬁed role of mitochondria and mitochondrial Ca2þ uptake
in cell death induction, representing a link between Ca2þ de-
regulation and apoptotic pathways outlined in the ﬁrst caption.3. The ER–mitochondrial interplay in the Ca2+ scene
Mitochondria take up Ca2þ avidly from the cytoplasm
during agonist induced Ca2þ signals due to the strong driving
force ensured by their membrane potential ()180 mV, negativeinside) built by the respiratory chain of the inner mitochon-
drial membrane (IMM) [21,22]. The molecular nature of the
channel responsible for Ca2þ uptake [mitochondrial Ca2þ
uniporter (MCU)] is still not known, but Ca2þ uptake and
electrophysiology measurements on isolated mitochondria
showed that it is a highly selective Ca2þ channel and requires
high external [Ca2þ] for its opening [23,24]. In fact, eﬃcient
mitochondrial Ca2þ uptake in intact cells was shown to be
dependent on the close apposition of mitochondria to Ca2þ
release (ER) and entry sites (plasma membrane), where micr-
odomains with high [Ca2þ] are formed [25,26]. Ca2þ dependent
stimulation of NAD(P)H and consequent ATP production,
through activation of Ca2þ sensitive dehydrogenases and me-
tabolite carriers, serves to adapt energy and substrate pro-
duction to increased cellular needs [27]. In addition,
mitochondria serve also as an intracellular Ca2þ buﬀer shaping
global cellular Ca2þ signals [28,29].
On the other hand, mitochondrial Ca2þ overload has been
shown to play a crucial role in apoptosis induction caused by
certain pro-apoptotic stimuli, acting both onmitochondrial and
ER, such as C2 ceramide [20,30]. What is the Ca
2þ source from
which such a sustained [Ca2þ]m increase has its origin? The
above depicted high [Ca2þ] microdomains are obvious candi-
dates in the case where an apoptotic stimulus is suﬃcient to
maintain [Ca2þ] for prolonged periods. Indeed, C2 ceramidewas
shown to directly induce Ca2þ release from the ER Ca2þ store
[31] and also to sensitize mitochondria to Ca2þ impulses from
inositol 1,4,5 trisphosphate receptor (InsP3R) or ryanodine re-
ceptor (RyR) mediated Ca2þ release, leading to mitochondrial
permeability transition (MPT) and depolarization. This is fol-
lowed by the release of pro-apoptotic factors activating the ef-
fector caspases and ﬁnally triggering apoptotic cell death [32].
On the other hand,mitochondrial Ca2þ uptake directly from the
cytoplasm for prolonged periods may also lead to signiﬁcant
Ca2þ accumulation, even if the mean elevation does not exceed
the micromolar level [33,34]. While mitochondrial Ca2þ uptake
following Ca2þ inﬂux in muscle and neuronal cells may repre-
sent examples for the latter mechanism, a recent line of evidence
suggests that the ER–mitochondrial connection may have a
prominent role also in cell death induction.4. The key role of ER Ca2+ content and release in mitochondrial
Ca2+ overload and induction of cell death
The ﬁrst observations pointing to a major role of the re-
leasable Ca2þ pool of the ER came from the exploration of the
mechanism of antiapoptotic action of BCL-2 [35–39]. BCL-2
has been detected in association with the outer mitochondrial
membrane (OMM), with the ER and with the nucleus and a
cytoplasmic form of BCL-2 is also known to exist [40,41]. It has
been suggested that the distribution of the membrane bound
form p26-BCL-2-a in membranes renders it capable of partic-
ipating in the formation of multi-protein complexes [42] and,
accordingly, inhibition of apoptosis by BCL-2 has been sug-
gested to be due to its capacity to interact with other anti- or
pro-apoptotic proteins such as BCL-XL, BAX procasp-8 and
p28-BAP31 [43–46]. On the other hand, an eﬀect on cellular ion
homeostasis is suggested by the observation that BCL-2 forms
ion channels of limited cation selectivity when added to lipid
bilayers, thus potentially interfering with ion ﬂuxes in organ-
elles [47,48].
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action of the BCL-2 protein was still debated, the indications
that it is localized in key organelles of cellular Ca2þ handling
(the mitochondria and the ER) and that it may act as ion
channel led many groups to investigate whether the overex-
pression of this oncogene was aﬀecting the cellular and orga-
nelle Ca2þ homeostasis. The ﬁrst evidence of an eﬀect of
BCL-2 on ER Ca2þ homeostasis was obtained by Distelhorst
and coworkers [49], who showed a reduction in the thapsi-
gargin-induced eﬄux of Ca2þ from the ER in stably expressing
clones of WEHI7.2 lymphoma cells. In turn, the use of tar-
geted aequorins and GFP-based Ca2þ indicators allowed the
direct measurement of Ca2þ concentration in the ER of cells
transiently expressing BCL-2. It was shown that BCL-2 over-
expression in HeLa [31] or HEK-293 cells [50] causes a re-
duction of the steady state Ca2þ concentration in the
endoplasmic reticulum ([Ca2þ]er), and thus of the amount of
agonist-releasable Ca2þ pool, due to an increase in the Ca2þ
leak across the ER membrane [31]. Importantly, the observed
reduction of steady state [Ca2þ]er was modest (approx. 30%),
but suﬃcient to reduce agonist induced [Ca2þ] increase in the
cytoplasm and Ca2þ uptake into mitochondria. In this model,
apoptotic stimuli, known to act through Ca2þ release from the
ER, such as C2 ceramide, induced a prolonged increase in
[Ca2þ]m followed by dramatic alterations in the morphology of
mitochondria, i.e., swelling of the organelle and rupture of the
mitochondrial network. If, however, steady state [Ca2þ]er was
reduced not only by BCL-2 overexpression, but by a variety of
experimental approaches (incubation at lower extracellular
[Ca2þ], partial inhibition of the ER Ca2þ ATPase or overex-
pression of the plasma membrane Ca2þ ATPase), there was a
marked inhibition in apoptotic death and no mitochondrial
modiﬁcations occurred [20]. Similarly, following overexpres-
sion of calreticulin (an abundant luminal ER Ca2þ buﬀer)
which does not raise [Ca2þ]er, but does increase the releasable
Ca2þ pool, cell survival is drastically reduced upon C2-cera-
mide treatment [20]. Furthermore, cell lines derived from cal-
reticulin knock-out mice are more resistant to apoptosis,
indicating that the crucial requirement is the amount of re-
leased Ca2þ and not [Ca2þ]er [51].
Scorrano et al. [52] provided further evidence in favor of the
hypothesis that Ca2þ movement from the ER to mitochondria
is a key process in the activation of apoptosis by a number of
stimuli. They showed that mouse embryonic ﬁbroblasts deﬁ-
cient of the two pro-apoptotic proteins BAX and BAK (double
knock out, DKO, cells) are markedly resistant to a variety of
apoptotic stimuli and have a much reduced Ca2þconcentration
in the ER. If the ER Ca2þ levels are restored by recombinantly
overexpressing the sarcoplasmic-endoplasmic reticulum Ca2þ
ATPase (SERCA), not only mitochondrial Ca2þ uptake in
response to stimulation is re-established, but the cells regain
sensitivity to apoptotic stimuli such as arachidonic acid, C2-
ceramide and oxidative stress. These results are in keeping with
previous work by Ma et al. [53], demonstrating that SERCA
overexpression in Cos cells causes ER Ca2þ overload and in-
creases spontaneous apoptosis. The work of Scorrano and
colleagues further demonstrated that another group of apop-
totic stimuli (staurosporine and etoposide) are partially in-
sensitive to these alterations in the levels of ER Ca2þ, while
they require the presence of pro-apoptotic proteins on the
mitochondrial membrane. Thus, BAX speciﬁcally targeted to
the OMM did not induce any change in [Ca2þ]er but it madecells sensitive to apoptosis induced by the BH3-only protein
tBID.
The overall picture emerging from these studies is that an
important mechanism underlying the sensitivity of cells to
apoptosis is the up- and down-regulation of steady state
[Ca2þ]er by pro- and anti-apoptotic factors, respectively. The
resulting increase or decrease of Ca2þ release from the ER and
Ca2þ uptake into mitochondria in turn is pivotal in triggering
apoptotic signals.5. ER and mitochondria: what is between?
The works discussed above settled Ca2þ release from the ER
as a key component of cell death induction, but also promptly
evoke the question of the mechanism of Ca2þ transfer to the
mitochondria. Regarding this question up to now only few
data are available. The elegant work of Darios et al. put for-
ward a mechanism which presumes a very intimate connection
between these organelles without even the contribution of cy-
toplasmic Ca2þ increase [54]. In PC12 cells, following C2-cer-
amide treatment, inhibition of Ca2þ release through ryanodine
receptors was able to inhibit [Ca2þ]c increase but not the
prolonged [Ca2þ]m elevation and cell death induction. Fur-
thermore, they proposed that Ca2þ transfer implicates caspase-
8 activation, cleavage of BID, and tBID translocation to
mitochondria. Along these lines, proteins of the OMM lying
most likely in the route of Ca2þ transfer between the organelles
may have particularly important role in apoptotic Ca2þ sig-
naling. Indeed, overexpression of VDAC, the voltage-depen-
dent anion channel of the OMM [55], and tBID [56] enhances
mitochondrial Ca2þ uptake and in turn sensitizes the cells to
apoptotic stimuli. Thus, the expression level of VDAC (that is
upregulated in apoptosis-sensitive cells [57]) as well as mito-
chondrial translocation of the pro-apoptotic BCL-2 family
member may serve to regulate tunnelling Ca2þ in a restricted
space between ER and mitochondria.
In contrast to RyRs, very recently, InsP3 receptors have
been identiﬁed as an important component of ER-mitochon-
dria interaction by S.H Snyder’s group. They have shown, that
cytochrome c, after its initial Ca2þ dependent release from the
mitochondria translocates to the ER and interacts with InsP3
receptors, further augmenting Ca2þ release. This mechanism
serves in turn as a positive feed-back loop leading to a gen-
eralized form of cytochrome c release and cell death. DT40
cells lacking all three InsP3R isoforms thus are less sensitive to
apoptotic stimuli [58].6. Mitochondrial contribution to the eﬀector phase of apoptosis
One of the key events in mitochondrial apoptotic signaling is
the release of normal constituents [such as cytochrome c and
apoptosis inducing factor (AIF)] into the cytosol. Released
cytochrome c then binds to apoptotic protease activating fac-
tor-1 (APAF-1), which recruits and activates caspase-9 to form
the apoptosome and thus activates the eﬀector caspase-3. The
release of the content of the intermembrane space requires the
permeabilization of the OMM. Its mechanism and relation to
mitochondrial Ca2þ signaling, however, are still controversial.
The main components of the presumed mechanisms are the
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(such as BAX, BAK and tBID) to the OM, and the opening of
the PTP, with ensuing organelle swelling. Furthermore, reor-
ganization of the IMM structure, in parallel with changes of
the overall morphology of the mitochondrial reticulum, has
been proposed to play an important role in this process. The
potential mechanisms of OM permeabilization by extramito-
chondrial factors has been recently reviewed [59,60]. Here, we
discuss only their links to Ca2þ mediated pathways potentially
leading to pro-apoptotic factor release.
The ﬁrst obvious candidate proposed to link Ca2þ to cyto-
chrome c release is the process of MPT. This process leads to
massive swelling of the organelle (mostly described in isolated
mitochondria, [61], but see also [62]) and, importantly, the
rupture of the OMM [63]. The presumed basis for this process is
a multiprotein complex that transverses the intermembrane
space; the putative essential components of this complex are
VDAC in the OMM, the adenine nucleotide translocase (ANT)
in the IMM, and cyclophilin-D in the mitochondrial matrix.
The partial and transient PTP opening has been suggested to
drain the proton gradient in order to protect mitochondria
from hyperpolarization and increased reactive oxygen species
(ROS) production [64]. In contrast, complete and irreversible
PTP opening (induced, for example, by Ca2þ or ROS) renders
the mitochondria permeable to larger molecules, leading to a
complete loss of mitochondrial membrane potential and re-
spiratory function (for review see [61]). However, the active role
of PTP opening in inducing apoptosis has been questioned by
the fact that Ca2þ-induced permeability transition can occur in
BAX/BAK deﬁcient, non-apoptotic cells [65]. An alternative,
interesting possibility is that PTP serves as an anchor to target
these molecules to the OMM, close to contact sites where
OMM permeabilization occurs [62].
As an alternative, the phenomenon of mitochondrial frag-
mentation, which is prominent in several apoptotic models,
has been directly implicated in the transduction of apoptotic
signals involving OMM permeabilization [66–68]. These works
identiﬁed dynamin-like protein-1 (Drp-1, member of the large
GTPase mechanoenzyme family, mediating mitochondrial ﬁs-
sion) in complexes with pro-apoptotic members of the BCL-2
family at mitochondrial ﬁssion sites, such as BAX, which
mediate OMM permeabilization, release of cytochrome c and
induction of apoptosis [69]. Moreover, Drp-1 overexpression
ampliﬁed BAX-mediated release of cytochrome c induced by
the pro-apoptotic agent staurosporine [59,70]. Conversely,
expression of the GTPase mutant Drp-1K38A prevented mito-
chondrial scission together with cytochrome c release and cell
death without inhibiting BAX translocation to the OMM. A
simple model suggested recently is that morphological alter-
ation induced by Drp-1 is responsible for the OMM permea-
bilization [65,71]. Indeed, even if mild fragmentation of
mitochondria by Drp-1 overexpression has not been shown to
pro-apoptotic in itself, expression of its OM anchoring protein
hFis1 renders cells sensitive to the mitochondrial apoptotic
pathway [72]. Further studies are needed to clarify the role of
additional components (possibly present in complex with
BAX/Drp-1/hFis1) in OMM permeabilization (for reviews see
[73,74]). Regarding the role of Ca2þ signals, Shore and co-
workers showed that Ca2þ release from the ER by the BAP31
cleavage product p20 and subsequent mitochondrial Ca2þ ac-
cumulation precedes translocation of Drp1 to mitochondria,
i.e., the induction of mitochondrial fragmentation is strictlyCa2þ dependent [68]. Interestingly, in the model proposed, this
mitochondrial pathway serves as an ampliﬁcation loop to
augment caspase-8 mediated apoptosis.
In conclusion, recent developments in exploring Ca2þ de-
pendent processes in apoptotic pathways disclosed that several
aspects of mitochondrial participation in induction of apoptosis
rely upon Ca2þ regulated mechanisms. Among them the release
of pro- and anti-apoptotic factors from the intermembrane
space has been related to mitochondrial Ca2þ overload and
probably Ca2þ mediated morphological changes in mitochon-
drial network. Even if the exact mechanism and site of Ca2þ
action still awaits investigation, an important characteristic of
mitochondrial Ca2þ uptake/overload is its strict dependency on
changes of ER Ca2þ handling. In our review, we summarized
recent data strengthening this view. Discussion of further as-
pects of Ca2þ regulated processes in apoptosis has been recently
reviewed [32,75,76], including cytoplasmic sites of Ca2þ action
and changes in global Ca2þ signaling during apoptosis.
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